{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:34:02Z","timestamp":1777901642322,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231369"],"award-info":[{"award-number":["BK20231369"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The primary objective of this study is to investigate the potential of cardiac magnetic resonance (CMR) parameters to augment prognostic evaluation in patients with CTD-associated pulmonary arterial hypertension (CTD-PAH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective, single-centre cohort study was conducted on 110 patients with CTD-PAH who were diagnosed via right heart catheterization between 2017 and 2023. These patients underwent CMR examinations based on clinical indications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After a mean follow-up period of 27\u2009months, 27 patients experienced clinical deterioration events. After adjusting for age, sex and COMPERA 2.0 risk assessment model parameters, five CMR metrics were identified as independent risk factors for clinical deterioration in CTD-PAH patients. Receiver operating characteristic curve analysis showed that combining COMPERA 2.0 risk assessment model with CMR metrics improved predictive performance, with interventricular septum extracellular volume (IVS ECV) providing the greatest benefit among tissue metrics and right ventricular ejection fraction (RVEF) showing the most improvement among right heart function metrics. Kaplan-Meier\uff08KM\uff09\u00a0survival curves revealed that patients with RVEF &amp;lt;39.2% and IVS ECV &amp;gt;31.4% had the poorest prognosis. Calibration curves indicated that integrating RVEF and IVS ECV significantly enhanced the accuracy and reliability of the COMPERA 2.0 risk assessment model in predicting 1-, 2- and 3-year event-free survival rates in CTD-PAH patients, with the C-index improving from 0.626 to 0.805.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Combining RVEF and IVS ECV with COMPERA 2.0 risk assessment model significantly enhances the model\u2019s predictive accuracy for clinical deterioration in CTD-PAH patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf140","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:46:02Z","timestamp":1741700762000},"page":"4154-4163","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9745-2327","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangdi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linwei","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5607-9713","authenticated-orcid":false,"given":"Jiayi","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-0242","authenticated-orcid":false,"given":"Huangshu","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-3177","authenticated-orcid":false,"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-8192","authenticated-orcid":false,"given":"Yinsu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-6383","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2025070205015509200_keaf140-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2025070205015509200_keaf140-B2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"2025070205015509200_keaf140-B3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/eurheartj\/ehac355","article-title":"Cardiac magnetic resonance: challenges, opportunities, and developments","volume":"43","author":"Crea","year":"2022","journal-title":"Eur Heart J"},{"key":"2025070205015509200_keaf140-B4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jcmg.2020.11.022","article-title":"Cardiac magnetic resonance evaluation of pulmonary arterial hypertension: transforming from supplementary to primary imaging modality?","volume":"14","author":"Hulten","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025070205015509200_keaf140-B5","doi-asserted-by":"crossref","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"2025070205015509200_keaf140-B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2025070205015509200_keaf140-B7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/acr.25328","article-title":"Evaluation of the European Society of Cardiology risk assessment score in incident systemic sclerosis-associated pulmonary arterial hypertension","volume":"76","author":"Brown","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025070205015509200_keaf140-B8","doi-asserted-by":"crossref","first-page":"745578","DOI":"10.3389\/fcvm.2021.745578","article-title":"Validity of the ESC risk assessment in idiopathic pulmonary arterial hypertension in China","volume":"8","author":"Gong","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025070205015509200_keaf140-B9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025070205015509200_keaf140-B10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2025070205015509200_keaf140-B11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025070205015509200_keaf140-B12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2025070205015509200_keaf140-B13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1378\/chest.12-3023","article-title":"Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis","volume":"144","author":"Frost","year":"2013","journal-title":"Chest"},{"key":"2025070205015509200_keaf140-B14","doi-asserted-by":"crossref","first-page":"1802067","DOI":"10.1183\/13993003.02067-2018","article-title":"Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension","volume":"53","author":"Simpson","year":"2019","journal-title":"Eur Respir J"},{"key":"2025070205015509200_keaf140-B15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.110987","article-title":"Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease","volume":"39","author":"Rajaram","year":"2012","journal-title":"J Rheumatol"},{"key":"2025070205015509200_keaf140-B16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00330-016-4585-y","article-title":"Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension","volume":"27","author":"Roller","year":"2017","journal-title":"Eur Radiol"},{"key":"2025070205015509200_keaf140-B17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diii.2019.12.008","article-title":"Quantification of right ventricular extracellular volume in pulmonary hypertension using cardiac magnetic resonance imaging","volume":"101","author":"Habert","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"2025070205015509200_keaf140-B18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mri.2021.03.011","article-title":"Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"79","author":"Alabed","year":"2021","journal-title":"Magn Reson Imaging"},{"key":"2025070205015509200_keaf140-B19","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025070205015509200_keaf140-B20","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"2025070205015509200_keaf140-B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCIMAGING.113.000629","article-title":"Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study","volume":"7","author":"Peacock","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025070205015509200_keaf140-B22","doi-asserted-by":"crossref","first-page":"e011430","DOI":"10.1161\/CIRCIMAGING.120.011430","article-title":"Prognostic importance of right ventricular-vascular uncoupling in acute decompensated heart failure with preserved ejection fraction","volume":"13","author":"Nakagawa","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025070205015509200_keaf140-B23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/rccm.201909-1771OC","article-title":"Identification of cardiac magnetic resonance imaging thresholds for risk stratification in pulmonary arterial hypertension","volume":"201","author":"Lewis","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025070205015509200_keaf140-B24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2023.07.028","article-title":"Toward the implementation of optimal cardiac magnetic resonance risk stratification in pulmonary arterial hypertension","volume":"165","author":"Celant","year":"2024","journal-title":"Chest"},{"key":"2025070205015509200_keaf140-B25","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/heartjnl-2023-322742","article-title":"Restoration of right ventricular function in the treatment of pulmonary arterial hypertension","volume":"109","author":"Celant","year":"2023","journal-title":"Heart"},{"key":"2025070205015509200_keaf140-B26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12968-017-0327-9","article-title":"Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort","volume":"19","author":"Petersen","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025070205015509200_keaf140-B27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1183\/09031936.00158014","article-title":"Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension","volume":"45","author":"Courand","year":"2015","journal-title":"Eur Respir J"},{"key":"2025070205015509200_keaf140-B28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025070205015509200_keaf140-B29","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/rheumatology\/keae141","article-title":"Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension","volume":"63","author":"Knight","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025070205015509200_keaf140-B30","first-page":"253","article-title":"Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension","volume":"7","author":"Patel","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025070205015509200_keaf140-B31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jacc.2014.04.031","article-title":"Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension","volume":"64","author":"Manders","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025070205015509200_keaf140-B32","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/rheumatology\/keaa721","article-title":"The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy","volume":"60","author":"Qiu","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025070205015509200_keaf140-B33","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1007\/s12410-014-9287-8","article-title":"T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure","volume":"7","author":"Maestrini","year":"2014","journal-title":"Curr Cardiovasc Imaging Rep"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf140\/62375490\/keaf140.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4154\/62375490\/keaf140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4154\/62375490\/keaf140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:02:09Z","timestamp":1751446929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/7\/4154\/8069460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,11]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf140","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,11]]}}}